Definition of an Normal Tissue Complication Probability Model for the Inner Ear in Definitive Radiochemotherapy of Nasopharynx Carcinoma
Open Access
Abstract
Background: Definitive radiochemotherapy is the treatment of choice for locally advanced nasopharyngeal carcinoma. Due to the vicinity of the nasopharynx to the inner ear and the use of ototoxic platinum-based chemotherapy, there is a risk for irreversible damage to the auditory system. To avoid or minimize these critical side effects, radiation exposure to each inner ear must be balanced between target volume coverage and toxicity. However, normal tissue complication probability (NTCP) models of the inner ear validated by clinical data are rare. Patients and Methods: This retrospective study investigates the inner ear toxicity of 46 patients who received radio(chemo-)therapy for nasopharyngeal carcinoma at our institution from 2004 to 2021 according to CTCAE criteria. For each inner ear, the mean and maximum dose in Gray was evaluated and correlated with clinical toxicity data. Based on the data, an NTCP model and a cutoff dose logistic regression model (CDLR) were created. Results: In 11 patients () hearing impairment and/or tinnitus was observed as a possible therapy-associated toxicity. was between 15– Gy, whereas was between 30– Gy. There was a dose-dependent, sigmoidal relation between inner ear dose and toxicity. A of Gy and Gy was associated with inner ear damage in and of patients, respectively. The maximum curve slope (m) was found at and is . The Dmax values showed a and complication probability at Gy and Gy, respectively, and a maximum slope of the sigmoid curve at with . Conclusion: There is a sigmoidal relation between radiation dose and incidence of inner ear toxicities. Dose constraints for the inner ear of Gy or Gy are suggested to limit the probability of inner ear toxicity .
Keywords
This publication has 30 references indexed in Scilit:
- Multivariate analysis of quality of life outcome for nasopharyngeal carcinoma patients after treatmentRadiotherapy and Oncology, 2010
- Radiation Therapy and Hearing LossInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Prospective Randomized Study of Intensity-Modulated Radiotherapy on Salivary Gland Function in Early-Stage Nasopharyngeal Carcinoma PatientsJournal of Clinical Oncology, 2007
- Ototoxicity after radiotherapy for head and neck tumorsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: Initial report on a randomized controlled clinical trialInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- The Enigmatic Epidemiology of Nasopharyngeal CarcinomaCancer Epidemiology, Biomarkers & Prevention, 2006
- Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinomaCancer, 2006
- Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patientsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Sensori-neural hearing loss in patients treated with irradiation for nasopharyngeal carcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1991
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958